These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 23430138)

  • 21. Performance Evaluation of Montelukast Pediatric Formulations: Part I-Age-Related In Vitro Conditions.
    Guimarães M; Somville P; Vertzoni M; Fotaki N
    AAPS J; 2022 Jan; 24(1):26. PubMed ID: 35013835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bioequivalence study of two generic formulations of 10 mg montelukast tablets in healthy Thai male volunteers.
    Sripalakit P; Maphanta S; Saraphanchotiwitthaya A
    Int J Clin Pharmacol Ther; 2010 Sep; 48(9):628-32. PubMed ID: 20860917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative bioavailability and pharmacokinetics of investigational enteric- and film-coated formulations of flurbiprofen 100-mg tablets: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Pakistani male volunteers.
    Ahmad M; Pervaiz F
    Clin Ther; 2010 Mar; 32(3):607-13. PubMed ID: 20399997
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comprehensive study of dynamic curing effect on tablet coating structure.
    Gendre C; Genty M; da Silva JC; Tfayli A; Boiret M; Lecoq O; Baron M; Chaminade P; Péan JM
    Eur J Pharm Biopharm; 2012 Aug; 81(3):657-65. PubMed ID: 22561957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Three-Pulse Release Tablet for Amoxicillin: Preparation, Pharmacokinetic Study and Physiologically Based Pharmacokinetic Modeling.
    Li J; Chai H; Li Y; Chai X; Zhao Y; Zhao Y; Tao T; Xiang X
    PLoS One; 2016; 11(8):e0160260. PubMed ID: 27479702
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the pharmacokinetics and tolerability of montelukast/levocetirizine administered as a fixed-dose combination and as separate tablets.
    Kim S; Ko JW; Kim JR
    Int J Clin Pharmacol Ther; 2018 Sep; 56(9):443-450. PubMed ID: 30021691
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bioequivalence of two film-coated tablets of imatinib mesylate 400 mg: a randomized, open-label, single-dose, fasting, two-period, two-sequence crossover comparison in healthy male South American volunteers.
    Parrillo-Campiglia S; Ercoli MC; Umpierrez O; Rodríguez P; Márquez S; Guarneri C; Estevez-Parrillo FT; Laurenz M; Estevez-Carrizo FE
    Clin Ther; 2009 Oct; 31(10):2224-32. PubMed ID: 19922893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Osmotically controlled pulsatile release capsule of montelukast sodium for chronotherapy: statistical optimization, in vitro and in vivo evaluation.
    Ranjan OP; Nayak UY; Reddy MS; Dengale SJ; Musmade PB; Udupa N
    Drug Deliv; 2014 Nov; 21(7):509-18. PubMed ID: 24215165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A new pressure-controlled colon delivery capsule for chronotherapeutic treatment of nocturnal asthma.
    Barakat NS; Al-Suwayeh SA; Taha EI; Bakry Yassin AE
    J Drug Target; 2011 Jun; 19(5):365-72. PubMed ID: 20681754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Compression-coated tablets of glipizide using hydroxypropylcellulose for zero-order release: in vitro and in vivo evaluation.
    Huang H; Wu Z; Qi X; Zhang H; Chen Q; Xing J; Chen H; Rui Y
    Int J Pharm; 2013 Mar; 446(1-2):211-8. PubMed ID: 23370433
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Preparation of pantoprazole sodium enteric-coated pellets-type tablets].
    Chen MM; Wang CR; Jin Y
    Yao Xue Xue Bao; 2011 Jan; 46(1):96-101. PubMed ID: 21465814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetic behavior of montelukast in indigenous healthy male volunteers.
    Fayyaz A; Khan JA; Ashraf MM; Akhter N; Aslam B; Khalid MF; Altaf S; Naseer RD; Akram M; Shah SMA; Khadam MW; Tahir IM
    Pak J Pharm Sci; 2017 Nov; 30(6(Supplementary)):2435-2439. PubMed ID: 29188782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative pharmacokinetics of a montelukast/levocetirizine fixed-dose combination chewable tablet versus individual administration of montelukast and levocetirizine after a single oral administration in healthy Korean male subjects
.
    Moon SJ; Yu KS; Jung J; Kim YI; Kim MG
    Int J Clin Pharmacol Ther; 2020 Jun; 58(6):354-362. PubMed ID: 32271144
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro and in vivo performance of a multiparticulate pulsatile drug delivery system.
    Mohamad A; Dashevsky A
    Drug Dev Ind Pharm; 2007 Feb; 33(2):113-9. PubMed ID: 17454042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Montelukast dose selection in children ages 2 to 5 years: comparison of population pharmacokinetics between children and adults.
    Knorr B; Nguyen HH; Kearns GL; Villaran C; Boza ML; Reiss TF; Rogers JD; Zhang J; Larson P; Spielberg S
    J Clin Pharmacol; 2001 Jun; 41(6):612-9. PubMed ID: 11402629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design of fixed dose combination and physicochemical characterization of enteric-coated bilayer tablet with circadian rhythmic variations containing telmisartan and pravastatin sodium.
    Luo D; Kim JH; Park C; Oh E; Park JB; Cui JH; Cao QR; Lee BJ
    Int J Pharm; 2017 May; 523(1):343-356. PubMed ID: 28330645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A case study exploring the impact of an oxygen barrier coating on formulation stability, in-vitro dissolution and bioperformance.
    Mann JC; Mitra A; Pygall SR
    J Pharm Pharmacol; 2012 Jan; 64(1):40-7. PubMed ID: 22150670
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative bioavailability study of single-dose film-coated and sugar-coated ethionamide tablets in healthy volunteers.
    Korth-Bradley JM; Mayer P; Mansfield D; Tucker H; Wu D
    Clin Ther; 2014 Jun; 36(6):982-7. PubMed ID: 24832559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In Vitro Dissolution Model Can Predict the in Vivo Taste Masking Performance of Coated Multiparticulates.
    Keeley A; Teo M; Ali Z; Frost J; Ghimire M; Rajabi-Siahboomi A; Orlu M; Tuleu C
    Mol Pharm; 2019 May; 16(5):2095-2105. PubMed ID: 30900905
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and evaluation of dapsone tablets coated for specific colon release.
    Barros PD; Dias IFT; Zanin GD; Bunhak ÉJ
    Drug Dev Ind Pharm; 2020 Feb; 46(2):246-252. PubMed ID: 31951762
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.